TrialMedical oncology (Northwood, London, England)2017

Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer.

Tsuyoshi Miyahara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.